Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation

被引:29
作者
Nosaka, T [1 ]
Kitamura, T [1 ]
机构
[1] Univ Tokyo, Inst Med Sci, Div Hematopoiet Factors, Tokyo 1088639, Japan
关键词
D O I
10.1016/S0301-472X(02)00808-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. BCR-ABL is a unique oncoprotein of which sole expression can cause cancer. A number of signaling molecules were shown to be activated by BCR-ABL. One of the important molecules that contributes to BCR-ABL-mediated cell proliferation is signal transducer and activator of transcription (STAT) 5. To elucidate the mechanism of BCR-ABL-mediated leukemogenesis, a role of pim-1, one of the important target genes of STAT5, was investigated. Materials and Methods. A temperature-sensitive mutant of p210(BCR-ABL) was introduced in interleukin-3-dependent murine hematopoietic cell line Ba/F3 cells, and downstream signaling after activation of BCR-ABL was investigated. Effects of the expression of a dominant-negative (dn) Pim-1 and a dn STAT5A in BCR-ABL-driven cell proliferation also were studied in Ba/F3 cells. Results. We found that pim-1 was markedly up-regulated following activation of BCR-ABL tyrosine kinase with activation of STAT5. Overexpression of pim-1 alone induced cytokine-independent cell growth of Ba/F3 cells in a dose-dependent manner. However, expression of the do Pim-1 did not affect growth of Ba/F3 cells transformed by BCR-ABL, whereas that of the dn STAT5A did suppress it. Conclusion. Pim-1 is one of the redundant molecules that contributes to induction of autonomous cell growth and is dispensable for leukemogenesis by BCR-ABL. (C) 2002 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:697 / 702
页数:6
相关论文
共 47 条
  • [1] THE HUMAN PROTOONCOGENE PRODUCT P33PIM IS EXPRESSED DURING FETAL HEMATOPOIESIS AND IN DIVERSE LEUKEMIAS
    AMSON, R
    SIGAUX, F
    PRZEDBORSKI, S
    FLANDRIN, G
    GIVOL, D
    TELERMAN, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8857 - 8861
  • [2] VERY HIGH-FREQUENCY OF LYMPHOMA INDUCTION BY A CHEMICAL CARCINOGEN IN PIM-1 TRANSGENIC MICE
    BREUER, M
    SLEBOS, R
    VERBEEK, S
    VANLOHUIZEN, M
    WIENTJENS, E
    BERNS, A
    [J]. NATURE, 1989, 340 (6228) : 61 - 63
  • [3] Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl
    Carlesso, N
    Frank, DA
    Griffin, JD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) : 811 - 820
  • [4] p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells
    Carpino, N
    Wisniewski, D
    Strife, A
    Marshak, D
    Kobayashi, R
    Stillman, B
    Clarkson, B
    [J]. CELL, 1997, 88 (02) : 197 - 204
  • [5] Chai SK, 1997, J IMMUNOL, V159, P4720
  • [6] STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells
    de Groot, RP
    Raaijmakers, JAM
    Lammers, JWJ
    Jove, R
    Koenderman, L
    [J]. BLOOD, 1999, 94 (03) : 1108 - 1112
  • [7] DOMEN J, 1993, BLOOD, V82, P1445
  • [8] PIM-1 LEVELS DETERMINE THE SIZE OF EARLY B-LYMPHOID COMPARTMENTS IN BONE-MARROW
    DOMEN, J
    VANDERLUGT, NMT
    ACTON, D
    LAIRD, PW
    LINDERS, K
    BERNS, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) : 1665 - 1673
  • [9] DOMEN J, 1993, LEUKEMIA S2, V7, P108
  • [10] Frank DA, 1996, LEUKEMIA, V10, P1724